Skip to main content

Table 7 Free fatty acid profile of HBV cirrhosis patients in comparison of controls

From: Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients

Fatty Acids (g/100 g) Controls Patients
C-14:0 1.29 ± 0.7 1.34 ± 0.9
C-16 : 0 19.84 ± 3.2 24.63 ± 5.1*
C-18 : 0 14.30 ± 5.6 17.80 ± 6.9
C-20 : 0 0.82 ± 0.5 0.16 ± 0.3*
C-24 : 0 0.11 ± 0.1 0.009 ± 0.03
C-14 : 1 0.14 ± 0.2 0.45 ± 0.4*
C-16 : 1 2.25 ± 0.8 3.58 ± 1.1*
C-18 : 1 22.50 ± 5.1 24.36 ± 3.1
C-22 : 1 1.70 ± 0.8 0.88 ± 0.6*
C-24 : 1 ND ND
C-18 : 2 27.99 ± 3.9 20.48 ± 3.8*
C-18 : 3 0.29 ± 0.1 0.07 ± 0.1
C-20 : 3 0.61 ± 0.4 0.18 ± 0.3
C-20 : 4 5.40 ± 2.4 2.55 ± 1.2*
C-20 : 5 0.54 ± 0.1 ND*
C-22 : 5 0.05 ± 0.1 0.12 ± 0.1
C-22 : 6 0.09 ± 0.2 0.33 ± 0.4*
  1. Values are mean ± standard deviation,* shows significant difference from HBV-cirrhosis patients with comparison of healthy controls a p < 0.05 (t-test). myristic acid (C14:0), myristoleic acid (C14:1), palmitic acid (C16:0), palmitoleic acid (C16:1), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), α-linolenic acid (C18:3), arachidic acid (C20:0), eicosatrienoic acid (C-20:3), arachidonic acid (C20:4), eicosapentaenoic acid (EPA (C20:5), docosenoic acid (C22:1), docosahexaenoic acid (DHA (C22:6), nervonic acid(C24:1), not detected (ND)